$267 Million is the total value of SV Health Investors, LLC's 8 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 55.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AHCO | New | ADAPTHEALTH CORP. | $107,033,000 | – | 2,911,677 | +100.0% | 40.09% | – |
| BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $57,209,000 | +66.4% | 1,915,274 | 0.0% | 21.43% | +29.4% | |
| STRO | SUTRO BIOPHARMA INC | $41,527,000 | +4.8% | 1,824,542 | 0.0% | 15.56% | -18.5% | |
| MSON | MISONIX, INC. | $33,186,000 | +56.7% | 1,694,017 | 0.0% | 12.43% | +21.9% | |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $20,176,000 | -21.4% | 449,951 | 0.0% | 7.56% | -38.9% | |
| AVRO | Sell | AVROBIO INC | $3,491,000 | -79.0% | 275,034 | -76.9% | 1.31% | -83.7% |
| XFOR | X4 PHARMACEUTICALS INC | $2,682,000 | +33.9% | 311,490 | 0.0% | 1.00% | +4.1% | |
| ASXC | New | ASENSUS SURGICAL, INC. | $1,658,000 | – | 510,142 | +100.0% | 0.62% | – |
| TRXC | Exit | TRANSENTERIX INC | $0 | – | -510,142 | -100.0% | -0.15% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -1,719,576 | -100.0% | -12.37% | – |
| AMWL | Exit | AMERICAN WELL CORP | $0 | – | -1,662,646 | -100.0% | -20.29% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- SVLSF VI, LLC #1
- SV Life Sciences Fund VI (GP), L.P. #2
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSENTERIX, INC. | 27 | Q4 2020 | 24.0% |
| OCULAR THERAPEUTIX, INC. | 24 | Q2 2020 | 35.9% |
| KALVISTA PHARMACEUTICALS INC | 17 | Q4 2020 | 31.0% |
| DECIPHERA PHARMACEUTICALS INC | 17 | Q3 2021 | 31.0% |
| CATABASIS PHARMACEUTICALS, INC. | 15 | Q4 2018 | 18.2% |
| X4 PHARMACEUTICALS INC | 15 | Q3 2022 | 3.2% |
| BICYCLE THERAPEUTICS PLC | 14 | Q3 2022 | 65.4% |
| SUTRO BIOPHARMA INC | 14 | Q4 2021 | 19.1% |
| ENTELLUS MED INC | 12 | Q4 2017 | 64.4% |
| AVROBIO INC | 12 | Q1 2021 | 41.6% |
View SV Health Investors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-14 |
View SV Health Investors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.